CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

The PhysioWave Pro™ scale measures the stiffness of the major blood vessel into which the heart pumps, the aorta. Stiffness increases with age, but excess stiffness among people of similar ages can be a warning sign of risk. It is established that increased vascular stiffness can predict the later development of high blood pressure, or hypertension, and a higher risk of cardiovascular disease.

SFA SELUTION4SFA is being conducted in over 30 centers in the US plus an additional 10 centers worldwide. The study will enroll 300 patients, with the aim of demonstrating the superiority of SELUTION SLR over balloon angioplasty (POBA). The primary efficacy endpoint is primary patency of the target lesion at 12 months and the primary safety endpoint is freedom from death at 30 days. Enrollment into the study will be complete by the end of 2023.

The BEAR Implant serves as a bridge to restore the patient’s own ACL and is the first medical technology that has been clinically proven to enable healing of a torn ACL. It is a paradigm shift from the current standard of care – reconstruction that replaces the ACL with a graft.

The first patients were enrolled at Kaleida Health’s Buffalo General Medical Center-Gates Vascular Institute in Buffalo, New York by Dr. Vijay Iyer, Chief of Cardiology at the University of Buffalo and Director, Structural Heart Interventions at Buffalo General Hospital advises Vivasure Medical .

“Widex SoundRelax is the latest evolution in our evidence-based approach to tinnitus treatment, which leverages patented fractal tones algorithmically generated within Widex hearing aids. First introduced for tinnitus patients through Widex Zen tones, we’ve expanded the tone choices and included new modulated wave-like sounds, offering more options to help all wearers, with or without tinnitus, combat stress and sustain health,” said Dana Helmink, Senior Director of Audiology and Clinical Education at Widex USA.